Consonance Capital Management LP - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 109 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.

Quarter-by-quarter ownership
Consonance Capital Management LP ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$11,263,000
-47.0%
3,766,817
-42.7%
1.36%
-40.2%
Q1 2021$21,237,000
+41.5%
6,575,000
+421.0%
2.26%
+1.4%
Q1 2014$15,005,0001,262,0122.23%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
BVF INC/IL 6,353,645$7,561,0000.31%
SPHERA FUNDS MANAGEMENT LTD. 1,476,000$1,756,0000.24%
EAM Investors, LLC 840,556$1,000,0000.22%
Gratus Capital, LLC 1,249,248$1,487,0000.16%
Ally Bridge Group (NY) LLC 86,242$103,0000.07%
MARINER INDEPENDENT ADVISOR NETWORK, LLC 1,252,822$1,491,0000.06%
Bleichroeder LP 250,000$298,0000.06%
GSA CAPITAL PARTNERS LLP 324,784$386,0000.05%
Polar Capital Holdings Plc 5,000,000$5,950,0000.04%
PLATINUM INVESTMENT MANAGEMENT LTD 545,508$649,0000.03%
View complete list of INFINITY PHARMACEUTICALS INC shareholders